远大医药港股通空最新增减持 (2025-12-29) 官网 ( 00512.hk)	市盈率	13.37	市净率	1.62	股息率	3.32%	上市时间1995-12-19股价7.83港币涨跌幅-0.51%成交金额2,565.06万港币换手率0.09%市值277.93亿港币H股市值277.93亿港币总股本35.50亿H股本35.50亿每手股数500上市至今年化投资收益率-6.15%港股通持仓占H股比例17.78% (49.53亿港币2026-01-21) 累计做空占H股比例1.76% (4.87亿港币2026-01-16)
所属三级行业药品 (恒生)	市盈率	33.02	市净率	3.19	股息率	1.02%	恒生:医疗保健业药品及生物科技药品
所属指数指数纳入纳出	恒生港股通创新药指数 (1.92%) 港股通创新药 (1.55%) 恒生生物科技指数 (1.27%) 港股创新药 (1.13%) 港股通创新药 (1.10%) 恒生创新药指数 (0.99%) 恒生医疗保健指数 (0.95%) HKC医药C (0.84%) 港股通高息精选 (0.73%) SHS创新药 (0.52%) 恒生综合中型股指数 (0.34%) 恒生综合中小型股指数 (0.26%) 恒生综合大中型股指数 (0.05%) (共13个) 展开更多
备注 (9):	双击编辑备注

发表讨论

远大医药(00512) - 历史董事名单

#	姓名	职衔	职位	委任日期	辞任日期
1	楊光	Executive Director		2023-06-30	--
2	周超	Executive Director		2023-06-02	--
3	史琳	Executive Director		2021-06-01	--
4	唐緯坤	Executive Director		2021-06-01	--
5	胡野碧	Independent Non Executive Director		2018-12-31	--
6	牛戰旗	Executive Director		2016-11-14	2023-06-21
7	裴更	Independent Non Executive Director - A/F		2011-05-12	--
8	張繼	Executive Director		2010-02-12	2016-11-11
9	張繼	Non Executive Director		2008-11-28	2010-02-12
10	邵岩	Executive Director		2008-10-17	2023-06-02
11	辛冬生	Independent Non Executive Director		2008-10-17	2011-05-12
12	胡鉑	Executive Director		2008-07-21	2021-06-01
13	劉程煒	Executive Director	Chairman	2008-07-21	2021-06-01
14	盧騏	Independent Non Executive Director		2008-06-25	2018-05-11
15	魏東	Independent Non Executive Director		2006-09-20	2008-07-21
16	楊越	Independent Non Executive Director		2006-09-20	2008-03-28
17	蘇彩雲	Independent Non Executive Director - A/F		2005-03-21	--
18	夏史東	Executive Director		2004-11-29	2008-07-21
19	胡敏	Executive Director		2004-11-29	2006-09-20
20	馬小堅	Independent Non Executive Director		2004-07-20	2006-06-29
21	黃偉健	Independent Non Executive Director - A/F		2004-02-28	2006-06-29
22	蕭兆齡	Executive Director		2003-11-04	2006-06-29
23	何錦虹	Executive Director		2002-06-21	2008-07-21
24	勞玉儀	Executive Director	Chairman	2002-03-19	2006-06-29